144 related articles for article (PubMed ID: 30545040)
1. Clinical Significance of CUB and Sushi Multiple Domains 1 Inactivation in Head and Neck Squamous Cell Carcinoma.
Jung AR; Eun YG; Lee YC; Noh JK; Kwon KH
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30545040
[TBL] [Abstract][Full Text] [Related]
2. Characterization CSMD1 in a large set of primary lung, head and neck, breast and skin cancer tissues.
Ma C; Quesnelle KM; Sparano A; Rao S; Park MS; Cohen MA; Wang Y; Samanta M; Kumar MS; Aziz MU; Naylor TL; Weber BL; Fakharzadeh SS; Weinstein GS; Vachani A; Feldman MD; Brose MS
Cancer Biol Ther; 2009 May; 8(10):907-16. PubMed ID: 19276661
[TBL] [Abstract][Full Text] [Related]
3. The Diverse Role of CUB and Sushi Multiple Domains 1 (CSMD1) in Human Diseases.
Ermis Akyuz E; Bell SM
Genes (Basel); 2022 Dec; 13(12):. PubMed ID: 36553598
[TBL] [Abstract][Full Text] [Related]
4. miR-10b exerts oncogenic activity in human hepatocellular carcinoma cells by targeting expression of CUB and sushi multiple domains 1 (CSMD1).
Zhu Q; Gong L; Wang J; Tu Q; Yao L; Zhang JR; Han XJ; Zhu SJ; Wang SM; Li YH; Zhang W
BMC Cancer; 2016 Oct; 16(1):806. PubMed ID: 27756250
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic inactivation and aberrant transcription of CSMD1 in squamous cell carcinoma cell lines.
Richter TM; Tong BD; Scholnick SB
Cancer Cell Int; 2005 Sep; 5():29. PubMed ID: 16153303
[TBL] [Abstract][Full Text] [Related]
6. Epithelial-mesenchymal transition gene signature is associated with prognosis and tumor microenvironment in head and neck squamous cell carcinoma.
Jung AR; Jung CH; Noh JK; Lee YC; Eun YG
Sci Rep; 2020 Feb; 10(1):3652. PubMed ID: 32107458
[TBL] [Abstract][Full Text] [Related]
7. Loss of CSMD1 expression is associated with high tumour grade and poor survival in invasive ductal breast carcinoma.
Kamal M; Shaaban AM; Zhang L; Walker C; Gray S; Thakker N; Toomes C; Speirs V; Bell SM
Breast Cancer Res Treat; 2010 Jun; 121(3):555-63. PubMed ID: 19669408
[TBL] [Abstract][Full Text] [Related]
8. Somatic mutations, allele loss, and DNA methylation of the Cub and Sushi Multiple Domains 1 (CSMD1) gene reveals association with early age of diagnosis in colorectal cancer patients.
Shull AY; Clendenning ML; Ghoshal-Gupta S; Farrell CL; Vangapandu HV; Dudas L; Wilkerson BJ; Buckhaults PJ
PLoS One; 2013; 8(3):e58731. PubMed ID: 23505554
[TBL] [Abstract][Full Text] [Related]
9. Gene-expression signature regulated by the KEAP1-NRF2-CUL3 axis is associated with a poor prognosis in head and neck squamous cell cancer.
Namani A; Matiur Rahaman M; Chen M; Tang X
BMC Cancer; 2018 Jan; 18(1):46. PubMed ID: 29306329
[TBL] [Abstract][Full Text] [Related]
10. The presence of multiple regions of homozygous deletion at the CSMD1 locus in oral squamous cell carcinoma question the role of CSMD1 in head and neck carcinogenesis.
Toomes C; Jackson A; Maguire K; Wood J; Gollin S; Ishwad C; Paterson I; Prime S; Parkinson K; Bell S; Woods G; Markham A; Oliver R; Woodward R; Sloan P; Dixon M; Read A; Thakker N
Genes Chromosomes Cancer; 2003 Jun; 37(2):132-40. PubMed ID: 12696061
[TBL] [Abstract][Full Text] [Related]
11. Transcriptomic analysis reveals key lncRNAs associated with ribosomal biogenesis and epidermis differentiation in head and neck squamous cell carcinoma.
Guo YZ; Sun HH; Wang XT; Wang MT
J Zhejiang Univ Sci B; 2018 Sept.; 19(9):674-688. PubMed ID: 30178634
[TBL] [Abstract][Full Text] [Related]
12. A transcriptional metabolic gene-set based prognostic signature is associated with clinical and mutational features in head and neck squamous cell carcinoma.
Xing L; Guo M; Zhang X; Zhang X; Liu F
J Cancer Res Clin Oncol; 2020 Mar; 146(3):621-630. PubMed ID: 32067104
[TBL] [Abstract][Full Text] [Related]
13. Application of Machine Learning in Developing a Novelty Five-Pseudogene Signature to Predict Prognosis of Head and Neck Squamous Cell Carcinoma: A New Aspect of "Junk Genes" in Biomedical Practice.
Xing L; Zhang X; Guo M; Zhang X; Liu F
DNA Cell Biol; 2020 Apr; 39(4):709-723. PubMed ID: 32045271
[TBL] [Abstract][Full Text] [Related]
14. Analysis of head and neck carcinoma progression reveals novel and relevant stage-specific changes associated with immortalisation and malignancy.
Veeramachaneni R; Walker T; Revil T; Weck A; Badescu D; O'Sullivan J; Higgins C; Elliott L; Liloglou T; Risk JM; Shaw R; Hampson L; Hampson I; Dearden S; Woodwards R; Prime S; Hunter K; Parkinson EK; Ragoussis J; Thakker N
Sci Rep; 2019 Aug; 9(1):11992. PubMed ID: 31427592
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of YAP1 activation in head and neck squamous cell carcinoma.
Eun YG; Lee D; Lee YC; Sohn BH; Kim EH; Yim SY; Kwon KH; Lee JS
Oncotarget; 2017 Dec; 8(67):111130-111143. PubMed ID: 29340043
[TBL] [Abstract][Full Text] [Related]
16. Carbonyl reductase 1 is a new target to improve the effect of radiotherapy on head and neck squamous cell carcinoma.
Yun M; Choi AJ; Lee YC; Kong M; Sung JY; Kim SS; Eun YG
J Exp Clin Cancer Res; 2018 Oct; 37(1):264. PubMed ID: 30376862
[TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of transcriptomics based hypoxia signatures in head- and neck squamous cell carcinoma.
Tawk B; Schwager C; Deffaa O; Dyckhoff G; Warta R; Linge A; Krause M; Weichert W; Baumann M; Herold-Mende C; Debus J; Abdollahi A
Radiother Oncol; 2016 Feb; 118(2):350-8. PubMed ID: 26711490
[TBL] [Abstract][Full Text] [Related]
18. Complement inhibitor CSMD1 acts as tumor suppressor in human breast cancer.
Escudero-Esparza A; Bartoschek M; Gialeli C; Okroj M; Owen S; Jirström K; Orimo A; Jiang WG; Pietras K; Blom AM
Oncotarget; 2016 Nov; 7(47):76920-76933. PubMed ID: 27764775
[TBL] [Abstract][Full Text] [Related]
19. Global Proteomics-based Identification and Validation of Thymosin Beta-4 X-Linked as a Prognostic Marker for Head and Neck Squamous Cell Carcinoma.
Chi LH; Chang WM; Chang YC; Chan YC; Tai CC; Leung KW; Chen CL; Wu AT; Lai TC; Li YJ; Hsiao M
Sci Rep; 2017 Aug; 7(1):9031. PubMed ID: 28831179
[TBL] [Abstract][Full Text] [Related]
20. Identification of genomic mutations associated with clinical outcomes of induction chemotherapy in patients with head and neck squamous cell carcinoma.
Ock CY; Son B; Keam B; Lee SY; Moon J; Kwak H; Kim S; Kim TM; Jeon YK; Kwon SK; Hah JH; Lee SH; Kwon TK; Kim DW; Wu HG; Sung MW; Heo DS
J Cancer Res Clin Oncol; 2016 Apr; 142(4):873-83. PubMed ID: 26677030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
